Health Condition 1: P299- Cardiovascular disorder originating in the perinatal period, unspecified
Conditions
Interventions
None listed
Sponsors
Dr Anup Thakur
Eligibility
Inclusion criteria
Inclusion criteria: All neonates with refractory shock who received vasopressin infusion at least for 24 hours from January 2016 to May 2021 will be included.
Exclusion criteria
Exclusion criteria: Neonates with congenital heart diseases or other lethal anomalies and those in whom data retrieval is inadequate will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Systolic, mean and diastolic blood pressure at baseline, 6, 12, 24, 48 and 72 hours of vasopressin therapy- Blood pressure recordings will be retrieved from nursesâ?? chart. Invasive blood pressure readings will be considered whenever available. 2.Heart rate at baseline, 6, 12, 24, 48 and 72 hours of vasopressin therapy. 3.Urine output at baseline, 6, 12, 24, 48 and 72 hours of vasopressin therapy. 4.Biochemical parameters such as pH, bicarbonate levels, base deficit, lactate and sodium levels before and in first 72 hours of vasopressin administration. Worst parameters will be taken. 5.Inotrope score at baseline, 6, 12, 24, 48 and 72 hours of vasopressin therapy. 6.Oxygenation index at baseline and during first 72 hours of vasopressin therapy. Worst parameters will be taken. Timepoint: baseline, 6, 12, 24, 48 and 72 hours of vasopressin therapy | — |
Secondary
| Measure | Time frame |
|---|---|
| not applicableTimepoint: not applicable | — |
Countries
India
Contacts
Public ContactDr Anup Thakur
Sir Ganga Ram Hospital
Outcome results
None listed